RELA is required for CD271 expression and stem-like characteristics in hypopharyngeal cancer.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 10 2022
Historique:
received: 06 04 2022
accepted: 19 10 2022
entrez: 23 10 2022
pubmed: 24 10 2022
medline: 26 10 2022
Statut: epublish

Résumé

CD271 (also referred to as nerve growth factor receptor or p75

Identifiants

pubmed: 36273237
doi: 10.1038/s41598-022-22736-6
pii: 10.1038/s41598-022-22736-6
pmc: PMC9588052
doi:

Substances chimiques

Adapalene 1L4806J2QF
NF-kappa B 0
Receptors, Nerve Growth Factor 0
RELA protein, human 0
Transcription Factor RelA 0
NGFR protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17751

Informations de copyright

© 2022. The Author(s).

Références

Semin Cancer Biol. 2020 Dec;67(Pt 1):74-82
pubmed: 31412296
Cancer Lett. 2019 Oct 1;461:144-152
pubmed: 31325530
Nat Commun. 2017 Dec 7;8(1):1988
pubmed: 29215016
Oral Oncol. 2020 Jun;105:104668
pubmed: 32247988
Cancer Res. 2011 Jan 15;71(2):404-12
pubmed: 21123453
Virchows Arch. 2005 May;446(5):475-82
pubmed: 15856292
Lab Invest. 2019 Sep;99(9):1349-1362
pubmed: 31019292
Head Neck. 2019 Mar;41(3):569-576
pubmed: 30570183
Stem Cells Int. 2021 Oct 23;2021:9941733
pubmed: 34725550
Sci Rep. 2020 Dec 9;10(1):21592
pubmed: 33299012
Sci Rep. 2016 Jul 29;6:30707
pubmed: 27469492
Bioinformatics. 1999 Jul-Aug;15(7-8):622-30
pubmed: 10487870
Oral Oncol. 2014 Oct;50(10):930-41
pubmed: 24177052
Mol Cancer Res. 2007 May;5(5):423-33
pubmed: 17510309
Bioinformatics. 2015 Apr 1;31(7):1120-3
pubmed: 25414360
Nat Commun. 2020 Nov 20;11(1):5911
pubmed: 33219226
PLoS One. 2013 Apr 23;8(4):e62002
pubmed: 23626764
Trends Biochem Sci. 2005 Jan;30(1):43-52
pubmed: 15653325
Trends Pharmacol Sci. 2021 Sep;42(9):772-788
pubmed: 34334250
Nature. 2010 Jul 1;466(7302):133-7
pubmed: 20596026
Breast Cancer Res. 2022 Jan 25;24(1):7
pubmed: 35078507
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Autophagy. 2018;14(6):1028-1042
pubmed: 29749806
Sci Rep. 2016 Sep 09;6:32681
pubmed: 27609304
BMC Cancer. 2009 Jan 10;9:9
pubmed: 19134212
Histochem Cell Biol. 2008 Jun;129(6):705-33
pubmed: 18461349
Cancer Sci. 2017 Mar;108(3):283-289
pubmed: 28064442
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Oncotarget. 2016 Mar 8;7(10):11018-32
pubmed: 26783961

Auteurs

Akira Nakazato (A)

Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.
Department of Head and Neck Surgery, Miyagi Cancer Center, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.
Department of Otolaryngology, University of Toyama, Sugitani, Toyama, Japan.

Mai Mochizuki (M)

Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Rie Shibuya-Takahashi (R)

Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Haruna Fujimori (H)

Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Keitaro Fujii (K)

Department of Head and Neck Surgery, Miyagi Cancer Center, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Satoshi Saijoh (S)

Department of Head and Neck Surgery, Miyagi Cancer Center, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Shinkichi Morita (S)

Department of Head and Neck Surgery, Miyagi Cancer Center, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Tomoko Yamazaki (T)

Department of Head and Neck Medical Oncology, Miyagi Cancer Center, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Takayuki Imai (T)

Department of Head and Neck Surgery, Miyagi Cancer Center, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Ikuro Sato (I)

Department of Pathology, Miyagi Cancer Center, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Kennichi Satoh (K)

Division of Gastroenterology, Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro, Miyaginoku, Sendai, Miyagi, 983-8536, Japan.

Kazunori Yamaguchi (K)

Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Kazuo Sugamura (K)

Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Jun Yasuda (J)

Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Kazuto Matsuura (K)

Department of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwanoha, Kashiwa, Chiba, Japan.

Hideo Shojaku (H)

Department of Otolaryngology, University of Toyama, Sugitani, Toyama, Japan.

Yukinori Asada (Y)

Department of Head and Neck Surgery, Miyagi Cancer Center, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan.

Keiichi Tamai (K)

Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, 47-1, Medeshima-Shiote, Natori, Miyagi, Japan. tamaikeiichi@med.tohoku.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH